Works matching IS 02683369 AND DT 2008 AND VI 42 AND IP 3

Results: 13

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.

Published in:

Bone Marrow Transplantation, 2008, v. 42, n. 3, p. 181, doi. 10.1038/bmt.2008.150

By:

Ocheni, S.;
Kroeger, N.;
Zabelina, T.;
Sobottka, I.;
Ayuk, F.;
Wolsche, C.;
Muth, A.;
Lellek, H.;
Petersen, L.;
Erttmann, R.;
Kabisch, H.;
Zander, A. R.;
Bacher, U.

Publication type:

Article

Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman–Diamond syndrome.

Published in:

Bone Marrow Transplantation, 2008, v. 42, n. 3, p. 159, doi. 10.1038/bmt.2008.151

By:

Bhatla, D.;
Davies, S. M.;
Shenoy, S.;
Harris, R. E.;
Crockett, M.;
Shoultz, L.;
Smolarek, T.;
Bleesing, J.;
Hansen, M.;
Jodele, S.;
Jordan, M.;
Filipovich, A. H.;
Mehta, P. A.

Publication type:

Article

Successful donor-lymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotype.

Published in:

2008

By:

Kordes, U.;
Binder, T. M. C.;
Eiermann, T. H.;
Hassenpflug-Diedrich, B.;
Hassan, M. A.;
Beutel, K.;
Nagy, M.;
Kabisch, H.;
Schneppenheim, R.

Publication type:

Letter

B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL.

Published in:

Bone Marrow Transplantation, 2008, v. 42, n. 3, p. 187, doi. 10.1038/bmt.2008.122

By:

Fronkova, E.;
Muzikova, K.;
Mejstrikova, E.;
Kovac, M.;
Formankova, R.;
Sedlacek, P.;
Hrusak, O.;
Stary, J.;
Trka, J.

Publication type:

Article

C4d staining is a valuable marker in identifying chronic GVHD in colonic biopsies following BMT.

Published in:

2008

By:

Zhang, P. L.;
Wilkerson, M. L.;
Schworer, C. M.

Publication type:

Letter

Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

Published in:

Bone Marrow Transplantation, 2008, v. 42, n. 3, p. 175, doi. 10.1038/bmt.2008.133

By:

Baker, K. S.;
Filipovich, A. H.;
Gross, T. G.;
Grossman, W. J.;
Hale, G. A.;
Hayashi, R. J.;
Kamani, N. R.;
Kurian, S.;
Kapoor, N.;
Ringdén, O.;
Eapen, M.

Publication type:

Article

Successful salvage with unrelated umbilical cord blood transplant for Hodgkin's disease relapsed following autologous stem cell transplant.

Published in:

2008

By:

Lim, S. H.;
Zhang, Y.;
Burris, C.;
Townsend, M.

Publication type:

Letter

Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population.

Published in:

Bone Marrow Transplantation, 2008, v. 42, n. 3, p. 201, doi. 10.1038/bmt.2008.135

By:

Levine, J. E.;
Barrett, A. J.;
Zhang, M.-J.;
Arora, M.;
Pulsipher, M. A.;
Bunin, N.;
Fort, J.;
Loberiza, F.;
Porter, D.;
Giralt, S.;
Drobyski, W.;
Wang, D.;
Pavletic, S.;
Ringden, O.;
Horowitz, M. M.;
Collins Jr, R.

Publication type:

Article

Pegfilgrastim successfully mobilizes megakaryocyte progenitors into the peripheral blood in subjects with solid tumours.

Published in:

Bone Marrow Transplantation, 2008, v. 42, n. 3, p. 167, doi. 10.1038/bmt.2008.147

By:

Willis, F.;
Theti, D.;
Dean, S.;
Bacon, P.;
Baker, N.;
Pettengel, R.

Publication type:

Article

Complete and durable remission in a patient with life-threatening scleromyxedema treated with high-dose melphalan and BU with auto-SCT.

Published in:

2008

By:

Cheng, T.;
Gnanakumar, V.;
Hegedus, C.;
Stewart, D. A.

Publication type:

Letter

Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2008, v. 42, n. 3, p. 197, doi. 10.1038/bmt.2008.152

By:

Mori, T.;
Watanabe, M.;
Kurotori-Sotome, T.;
Ito, C.;
Yamada, K.;
Yashima, T.;
Kobayashi, N.;
Kondo, S.;
Aisa, Y.;
Kato, J.;
Ogawa, Y.;
Tsubota, K.;
Shigematsu, N.;
Kubo, A.;
Ikeda, Y.;
Okamoto, S.

Publication type:

Article

Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.

Published in:

Bone Marrow Transplantation, 2008, v. 42, n. 3, p. 145, doi. 10.1038/bmt.2008.185

By:

Bacher, U.;
Zander, A. R.;
Haferlach, T.;
Schnittger, S.;
Fehse, B.;
Kröger, N.

Publication type:

Article

What is the optimal dosage of valganciclovir as preemptive therapy for CMV infection in allogeneic hematopoietic SCT?

Published in:

2008

By:

Candoni, A.;
Simeone, E.;
Tiribelli, M.;
Pipan, C.;
Fanin, R.

Publication type:

Letter